サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1537093

サル痘（エムポックス）診断薬の世界市場：アッセイ別、国別、製品別、場所別 - エグゼクティブコンサルタントガイド付き市場分析と予測（2024年～2028年）

Monkeypox (MPOX) Diagnostics Global Markets by Assay, by Country, by Product, and by Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2024 - 2028

出版日
ページ情報
英文 312 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
サル痘（エムポックス）診断薬の世界市場：アッセイ別、国別、製品別、場所別 - エグゼクティブコンサルタントガイド付き市場分析と予測（2024年～2028年）
出版日: 2024年08月19日
発行: Howe Sound Research
ページ情報: 英文 312 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

サル痘（エムポックス）は健康上の緊急事態とされています。世界各国政府は、この脅威をいち早く察知するため、広範な検査を実施する準備を進めています。体外診断業界には機会があふれています。

当レポートは、世界のサル痘（エムポックス）診断薬市場について調査し、市場の概要とともに、アッセイ別、国別、製品別、場所別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

  • サル痘診断の概要
  • 市場の定義
  • 調査手法
  • 視点：ヘルスケアとIVD業界

第3章 サル痘- 現在の科学

  • サル痘とは何か
  • アウトブレイク
  • 感染
  • 兆候と症状
  • 診断
  • 治療薬
  • サル痘と天然痘の関係

第4章 業界の概要

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 医薬品・試薬サプライヤー
    • 独立系臨床検査室
    • 公共の国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関

第5章 市場動向

  • 成長促進要因
  • 成長阻害要因
  • 診断技術開発

第6章 サル痘診断-最近の動向

第7章 主要企業のプロファイル

  • Abbott Laboratories
  • Aegis Science Corporation
  • Applied DNA Sciences
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • BioFire Diagnostics（bioMerieux）
  • BioGX
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Cepheid（Danaher）
  • Cerstest Biotec
  • Flow Health
  • Laboratory Corporation of America
  • Mayo Clinic Laboratories
  • Novacyt
  • Proof Diagnostics
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Sysmex
  • Thermo Fisher Scientific
  • Vela Diagnostics

第8章 サル痘の世界診断市場の概要

  • サル痘診断- 国別の世界市場概要
  • 世界のサル痘診断市場の概要（アッセイ別）
  • 世界のサル痘診断市場の概要（製品別）
  • 世界のサル痘診断市場の概要（地域別）

第9章 サル痘診断市場- アッセイ別

  • サル痘診断-PCR
  • サル痘診断-NGS
  • サル痘診断- 免疫測定
  • サル痘診断- その他

第10章 世界のサル痘診断市場- 製品別

  • サル痘診断- 機器
  • サル痘診断- 消耗品
  • サル痘診断- ソフトウェアとサービス

第11章 世界のサル痘診断市場- 場所別

  • サル痘診断- 病院
  • サル痘診断- クリニック/POL
  • サル痘診断- その他

第12章 付録

図表

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Five Factors Driving Growth
  • Table 3: Factors Limiting Growth
  • Table 4: Global Monkeypox Diagnostics Market by Country/Region
  • Table 5: Global Market by Assay
  • Table 6: Global Market by Product
  • Table 7: Global Market by Place
  • Table 8: Monkeypox Diagnostic PCR by Country
  • Table 9: Monkeypox Diagnostic NGS by Country
  • Table 10: Monkeypox Diagnostic Immunoassay by Country
  • Table 11: Monkeypox Diagnostic Other Assay by Country
  • Table 12: Monkeypox Diagnostic Instrumentation by Country
  • Table 13: Monkeypox Diagnostic Consumables by Country
  • Table 14: Monkeypox Diagnostic Software & Service by Country
  • Table 15: Monkeypox Diagnostic Hospital by Country
  • Table 16: Monkeypox Diagnostic Clinic/POL by Country
  • Table 17: Monkeypox Diagnostic Other Place by Country
  • Table 18: Commercially Available Monkeypox Tests
  • Table 19: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Recent Global Cases
  • Figure 2: Total Cases Outside Endemic Africa
  • Figure 3: World Prevalence map
  • Figure 4: Growth in Health Care Spending Developing World
  • Figure 5: Comparing The New Diagnostics and Traditional Testing
  • Figure 6: Global Market Share Chart
  • Figure 7: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 8: Monkeypox Diagnostics Market by Assay Base Year
  • Figure 9: Monkeypox Diagnostics Market by Assay Final Year
  • Figure 10: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 11: Monkeypox Diagnostics Market by Product Base Year
  • Figure 12: Monkeypox Diagnostics Market by Product Final Year
  • Figure 13: Monkeypox Diagnostics Market Segment Shift Base vs Final year
  • Figure 14: Monkeypox Diagnostics Market by Place Base Year
  • Figure 15: Monkeypox Diagnostics Market by Place Final Year
  • Figure 16: Monkeypox Diagnostics Syndromic POC Panel Growth
  • Figure 17: Monkeypox Diagnostic NGS Growth
  • Figure 18: Monkeypox Diagnostic Immunoassay Growth
  • Figure 19: Monkeypox Diagnostic Other Assay Growth
  • Figure 20: Monkeypox Diagnostic Instrumentation Growth
  • Figure 21: Monkeypox Diagnostics Consumables
  • Figure 22: Monkeypox Diagnostic Software & Service Growth
  • Figure 23: Monkeypox Diagnostic GastroIntestinal Growth
  • Figure 24: Monkeypox Diagnostic Clinic/POL Growth
  • Figure 25: Monkeypox Diagnostics Other Place
目次

OVERVIEW:

Monkeypox is being declared a health emergency. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities abound for the In Vitro Diagnostic Industry.

The report forecasts the market size out to 2028. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. An Overview of Monkeypox Diagnostics
    • 2.1.1. The 2022 Outbreak
  • 2.2. Market Definition
    • 2.2.1. Market Size
    • 2.2.2. Currency
    • 2.2.3. Years
    • 2.2.4. PCR
    • 2.2.5. NGS
    • 2.2.6. Immunoassay
    • 2.2.7. Rapid Diagnostics
    • 2.2.8. Limitations
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Monkeypox - Current Science

  • 3.1. What is Monkeypox?
  • 3.2. Outbreaks
  • 3.3. Transmission
  • 3.4. Signs and symptoms
  • 3.5. Diagnosis
  • 3.6. Therapeutics
    • 3.6.1. Vaccination
    • 3.6.2. Prevention
      • 3.6.2.1. Reducing the risk of human-to-human transmission
      • 3.6.2.2. Reducing the risk of zoonotic transmission
  • 3.7. How monkeypox relates to smallpox

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Pharmaceutical/Reagent Supplier
    • 4.1.4. Independent Testing Lab
    • 4.1.5. Public National/regional lab
    • 4.1.6. Hospital lab
    • 4.1.7. Physician Lab
    • 4.1.8. Audit Body
    • 4.1.9. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Prevalence
    • 5.1.2. Surveillance
    • 5.1.3. Pandemic Wind Down
    • 5.1.4. Viral Zeitqeist
    • 5.1.5. Healthcare Spend
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve Shrinks the Market
    • 5.2.2. Transmission Outlook
    • 5.2.3. Adoption Lag and Cost Control
  • 5.3. Diagnostic Technology Development
    • 5.3.1. The Multiplex Opportunity
    • 5.3.2. Shifting Role of Physicians in Diagnosis
    • 5.3.3. Diagnostics Moves Out of the Lab
    • 5.3.4. Biomarkers and Algorithms
    • 5.3.5. Rapid Testing Changing Medical Practice
    • 5.3.6. Genome Role and Big Data

6. Mpox Diagnostics - Recent Developments

  • 6.1. Recent Developments - Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. WHO Declares MPOX a Health Emergency
  • 6.3. Human monkeypox disease prediction
  • 6.4. Most Dangerous Monkeypox Virus Yet
  • 6.5. South Africa reports second mpox death
  • 6.6. New Strain of MPOX Raising Alarm
  • 6.7. Labcorp Receives EUA for Home Mpox Test
  • 6.8. Ultrasensitive single-step CRISPR detection of MPOX virus
  • 6.9. Many new mpox cases are in China
  • 6.10. U.S. to declare monkeypox a public health emergency
  • 6.11. BioGX Gets CE-IVD Mark for Multigene POC Test
  • 6.12. World Health Organization declares monkeypox a global emergency
  • 6.13. Quest Begins Offering Internally Developed Monkeypox Test
  • 6.14. CDC, Abbott, Roche, BioMerieux Get FDA 510(k) Clearances
  • 6.15. Commercial, Academic Labs Ramp Up Monkeypox Testing
  • 6.16. Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx
  • 6.17. Monkeypox Virus Sequenced

7. Profiles of Key Companies

  • 7.1. Abbott Laboratories
  • 7.2. Aegis Science Corporation
  • 7.3. Applied DNA Sciences
  • 7.4. Beckman Coulter Diagnostics (Danaher)
  • 7.5. Becton, Dickinson and Company
  • 7.6. BGI Genomics Co. Ltd
  • 7.7. BioFire Diagnostics (bioMerieux)
  • 7.8. BioGX
  • 7.9. bioMerieux Diagnostics
  • 7.10. Bio-Rad Laboratories, Inc.
  • 7.11. Cepheid (Danaher)
  • 7.12. Cerstest Biotec
  • 7.13. Flow Health
  • 7.14. Laboratory Corporation of America
  • 7.15. Mayo Clinic Laboratories
  • 7.16. Novacyt
  • 7.17. Proof Diagnostics
  • 7.18. Qiagen
  • 7.19. Quest Diagnostics
  • 7.20. Roche Diagnostics
  • 7.21. Siemens Healthineers
  • 7.22. Sonic Healthcare
  • 7.23. Sysmex
  • 7.24. Thermo Fisher Scientific
  • 7.25. Vela Diagnostics

8. Monkeypox Global Diagnostic Markets Overview

  • 8.1. Monkeypox Diagnostics - Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Monkeypox Diagnostics Markets Overview by Assay
    • 8.2.1. Table - Global Market by Assay
    • 8.2.2. Chart - Global Market by Assay - Segments Growth
    • 8.2.3. Chart - Global Market by Assay - Share by Year
    • 8.2.4. Chart - Global Market by Assay
    • 8.2.5. Chart - Global Market by Assay - Base Year
    • 8.2.6. Chart - Global Market by Assay - Final Year
  • 8.3. Global Monkeypox Diagnostics Markets Overview by Product
    • 8.3.1. Table - Global Market by Product
    • 8.3.2. Chart - Global Market by Product - Segments Growth
    • 8.3.3. Chart - Global Market by Product - Share by Year
    • 8.3.4. Chart - Global Market by Product
    • 8.3.5. Chart - Global Market by Product - Base Year
    • 8.3.6. Chart - Global Market by Product - Final Year
  • 8.4. Global Monkeypox Diagnostics Markets Overview by Place
    • 8.4.1. Table - Global Market by Place
    • 8.4.2. Chart - Global Market by Place - Segments Growth
    • 8.4.3. Chart - Global Market by Place - Share by Year
    • 8.4.4. Chart - Global Market by Place
    • 8.4.5. Chart - Global Market by Place - Base Year
    • 8.4.6. Chart - Global Market by Place - Final Year

9. Monkeypox Diagnostic Market - by Assay

  • 9.1. Monkeypox Diagnostic - PCR
    • 9.1.1. Table Monkeypox Diagnostic PCR - by Country
    • 9.1.2. Chart - Monkeypox Diagnostic PCR Growth
  • 9.2. Monkeypox Diagnostic - NGS
    • 9.2.1. Table Monkeypox Diagnostic NGS - by Country
    • 9.2.2. Chart - Monkeypox Diagnostic - NGS Growth
  • 9.3. Monkeypox Diagnostic - Immunoassay
    • 9.3.1. Table Monkeypox Immunoassay - by Country
    • 9.3.2. Chart - Monkeypox Diagnostic - Immunoassay Growth
  • 9.4. Monkeypox Diagnostic - Other Assay
    • 9.4.1. Table Monkeypox Diagnostic Other Assay - by Country
    • 9.4.2. Chart - Monkeypox Diagnostic - Other Assay Growth

10. Global Monkeypox Diagnostics Markets - By Product

  • 10.1. Monkeypox Diagnostic - Instrumentation
    • 10.1.1. Table Monkeypox Diagnostic Instrumentation - by Country
    • 10.1.2. Chart - Monkeypox Diagnostic Instrumentation Growth
  • 10.2. Monkeypox Diagnostic - Consumables
    • 10.2.1. Table Monkeypox Diagnostic Consumables - by Country
    • 10.2.2. Chart - Monkeypox Diagnostic Consumables
  • 10.3. Monkeypox Diagnostic - Software & Service
    • 10.3.1. Table Monkeypox Diagnostic Software & Service - by Country
    • 10.3.2. Chart - Monkeypox Diagnostic - Software & Service Growth

11. Global Monkeypox Diagnostics Markets - By Place

  • 11.1. Monkeypox Diagnostic - Hospital
    • 11.1.1. Table Monkeypox Diagnostic Hospital - by Country
    • 11.1.2. Chart - Monkeypox Diagnostic Hospital Growth
  • 11.2. Monkeypox Diagnostic - Clinic/POL
    • 11.2.1. Table Monkeypox Diagnostic Clinic/POL - by Country
    • 11.2.2. Chart - Monkeypox Diagnostic Clinic/POL Growth
  • 11.3. Monkeypox Diagnostic - Other Place
    • 11.3.1. Table Monkeypox Diagnostic Other Place - by Country
    • 11.3.2. Chart - Monkeypox Diagnostic Other Place

12. Appendices

  • 12.1. Commercially Available Monkeypox Tests
  • 12.2. United States Medicare System: Clinical Laboratory Fees Schedule